Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 927871-76-9 | MDL No. : | MFCD12546447 |
Formula : | C11H15NOS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BGVCEGVSQDOGSB-UHFFFAOYSA-N |
M.W : | 209.31 | Pubchem ID : | 24763624 |
Synonyms : |
|
Chemical Name : | 7-Methoxy-4-methyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine |
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.45 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 63.93 |
TPSA : | 37.77 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.15 cm/s |
Log Po/w (iLOGP) : | 2.64 |
Log Po/w (XLOGP3) : | 2.01 |
Log Po/w (WLOGP) : | 1.7 |
Log Po/w (MLOGP) : | 2.0 |
Log Po/w (SILICOS-IT) : | 2.48 |
Consensus Log Po/w : | 2.17 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.66 |
Solubility : | 0.463 mg/ml ; 0.00221 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.43 |
Solubility : | 0.777 mg/ml ; 0.00371 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.2 |
Solubility : | 0.133 mg/ml ; 0.000637 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.45 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 145903-31-7 ]
7-Methoxy-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine
Similarity: 0.97
[ 1417789-77-5 ]
(R)-3-((2-Methoxyphenyl)thio)pyrrolidine hydrochloride
Similarity: 0.72
[ 63675-74-1 ]
6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophene
Similarity: 0.68
[ 1889802-11-2 ]
5-(5-Methoxybenzo[b]thiophen-2-yl)-1H-pyrrole-2-carboxylic acid
Similarity: 0.66
[ 622864-56-6 ]
5-Methoxybenzo[b]thiophene-2-carbaldehyde
Similarity: 0.66
[ 145903-31-7 ]
7-Methoxy-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine
Similarity: 0.97
[ 440627-14-5 ]
11-Oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxylic acid
Similarity: 0.61
[ 28783-41-7 ]
4,5,6,7-Tetrahydrothieno[3,2-c]pyridine hydrochloride
Similarity: 0.59
[ 116118-99-1 ]
4,5,6,7-Tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid hydrochloride
Similarity: 0.58
[ 1080026-94-3 ]
Ethyl 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylate
Similarity: 0.58